Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,406,487
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
49,877,027
-
Shares change
-
+78,419
-
Total reported value, excl. options
-
$504,757,759
-
Value change
-
+$349,413
-
Put/Call ratio
-
68%
-
Number of buys
-
85
-
Number of sells
-
-51
-
Price
-
$10.12
Significant Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q2 2023
173 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,877,027 shares
of 52,406,487 outstanding shares and own 95% of the company stock.
Largest 10 shareholders include Kynam Capital Management, LP (4,890,706 shares), BlackRock Inc. (4,135,184 shares), VANGUARD GROUP INC (3,477,674 shares), STATE STREET CORP (3,060,206 shares), MILLENNIUM MANAGEMENT LLC (2,895,476 shares), WELLINGTON MANAGEMENT GROUP LLP (2,879,922 shares), BAKER BROS. ADVISORS LP (2,497,526 shares), ORBIMED ADVISORS LLC (2,391,628 shares), Casdin Capital, LLC (2,023,913 shares), and GOLDMAN SACHS GROUP INC (1,624,252 shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.